These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 25275076)
1. Improvement of high-sensitivity inflammation-based Glasgow prognostic score by gastrectomy is a favorable prognostic factor in patients with gastric cancer. Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y Anticancer Res; 2014 Oct; 34(10):5695-702. PubMed ID: 25275076 [TBL] [Abstract][Full Text] [Related]
2. The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor in patients with resectable gastric cancer. Takeno S; Hashimoto T; Shibata R; Maki K; Shiwaku H; Yamana I; Yamashita R; Yamashita Y Oncology; 2014; 87(4):205-14. PubMed ID: 25034097 [TBL] [Abstract][Full Text] [Related]
3. Inflammation-based prognostic score predicts survival in patients with advanced gastric cancer receiving biweekly docetaxel and s-1 combination chemotherapy. Kunisaki C; Takahashi M; Ono HA; Oshima T; Takagawa R; Kimura J; Kosaka T; Makino H; Akiyama H; Endo I Oncology; 2012; 83(4):183-91. PubMed ID: 22890015 [TBL] [Abstract][Full Text] [Related]
4. Glasgow prognostic score is a useful predictive factor of outcome after palliative gastrectomy for stage IV gastric cancer. Mimatsu K; Oida T; Fukino N; Kano H; Kawasaki A; Kida K; Kuboi Y; Amano S Anticancer Res; 2014 Jun; 34(6):3131-6. PubMed ID: 24922683 [TBL] [Abstract][Full Text] [Related]
5. Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment. Melling N; GrĂ¼ning A; Tachezy M; Nentwich M; Reeh M; Uzunoglu FG; Vashist YK; Izbicki JR; Bogoevski D Surgery; 2016 Jun; 159(6):1548-1556. PubMed ID: 26899471 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of an inflammation-based prognostic system for gastric cancer patients with a preoperative normal serum level of carcinoembryonic antigen. Ishizuka M; Oyama Y; Abe A; Tago K; Tanaka G; Kubota K Anticancer Res; 2014 Dec; 34(12):7219-26. PubMed ID: 25503152 [TBL] [Abstract][Full Text] [Related]
7. Preoperative C-reactive protein and operative blood loss predict poor prognosis in patients with gastric cancer after laparoscopy-assisted gastrectomy. Ishino Y; Saigusa S; Ohi M; Yasuda H; Tanaka K; Toiyama Y; Mohri Y; Kusunoki M Asian J Endosc Surg; 2014 Nov; 7(4):287-94. PubMed ID: 25123708 [TBL] [Abstract][Full Text] [Related]
8. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence. Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360 [TBL] [Abstract][Full Text] [Related]
9. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063 [TBL] [Abstract][Full Text] [Related]
10. Inflammation-based prognostic score as a predictor of postoperative gastric cancer recurrence. Mohri Y; Tanaka K; Ohi M; Toiyama Y; Yasuda H; Inoue Y; Uchida K; Kusunoki M Anticancer Res; 2012 Oct; 32(10):4581-4. PubMed ID: 23060589 [TBL] [Abstract][Full Text] [Related]
11. Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater. Shiba H; Misawa T; Fujiwara Y; Futagawa Y; Furukawa K; Haruki K; Iwase R; Wakiyama S; Ishida Y; Yanaga K Anticancer Res; 2013 Jun; 33(6):2715-21. PubMed ID: 23749931 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. Hirashima K; Watanabe M; Shigaki H; Imamura Y; Ida S; Iwatsuki M; Ishimoto T; Iwagami S; Baba Y; Baba H J Gastroenterol; 2014 Jun; 49(6):1040-6. PubMed ID: 23821018 [TBL] [Abstract][Full Text] [Related]
13. The prognosis of gastric cancer patients with marginally elevated carcinoembryonic antigen (CEA) values after D2 radical gastrectomy. Chen S; Feng XY; Li YF; Zhao BW; Zhou ZW; Chen YB J Surg Oncol; 2013 May; 107(6):641-5. PubMed ID: 23297055 [TBL] [Abstract][Full Text] [Related]
14. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer. Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422 [TBL] [Abstract][Full Text] [Related]
15. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109 [TBL] [Abstract][Full Text] [Related]
16. Significance of modified Glasgow prognostic score as a useful indicator for prognosis of patients with gastric carcinoma. Nozoe T; Iguchi T; Egashira A; Adachi E; Matsukuma A; Ezaki T Am J Surg; 2011 Feb; 201(2):186-91. PubMed ID: 20832047 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of pre- and postoperative glasgow prognostic score for patients with non-small cell lung cancer. Tomita M; Ayabe T; Chosa E; Nakamura K Anticancer Res; 2014 Jun; 34(6):3137-40. PubMed ID: 24922684 [TBL] [Abstract][Full Text] [Related]
18. [The impact of preoperative weight loss for gastric cancer patients after gastrectomy]. Cui J; Liang H; Deng J; Ding X; Pan Y; Wang X; Wang B; Wu L; Jiang N Zhonghua Wai Ke Za Zhi; 2014 Jun; 52(6):409-14. PubMed ID: 25219554 [TBL] [Abstract][Full Text] [Related]
19. The value of the systematic inflammation-based Glasgow Prognostic Score in patients with gastric cancer: a literature review. Gao Y; Huang D J Cancer Res Ther; 2014; 10(4):799-804. PubMed ID: 25579511 [TBL] [Abstract][Full Text] [Related]
20. Value of preoperative inflammation-based prognostic scores in predicting overall survival and disease-free survival in patients with gastric cancer. Aurello P; Tierno SM; Berardi G; Tomassini F; Magistri P; D'Angelo F; Ramacciato G Ann Surg Oncol; 2014 Jun; 21(6):1998-2004. PubMed ID: 24515568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]